The FDA approved elinzanetant (Lynkuet), a new type of nonhormonal drug to treat disruptive menopausal hot flashes, Bayer ...
On Friday, the FDA approved Bayer’s dual neurokinin (NK) targeted therapy elinzanetant, which will now be marketed in the U.S ...
Bayer announced today the U.S. Food and Drug Administration (FDA) has approved Lynkuet® (elinzanetant) 60mg capsules, the first and only dual neurokinin (NK) targeted therapy,1 neurokinin 1 (NK1) and ...
First and only therapy FDA approved in both R/R acute myeloid leukemia (AML) with an NPM1 mutation and R/R acute leukemia with a KMT2A translocation - ...
Elanco Animal Health Incorporated today announced it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for Credeliotm (lotilaner) to treat New World ...
Rift Valley Fever (RVF) is a viral disease transmitted by mosquitoes that mainly affects livestock. It can also infect humans ...
EUA to Treat Dogs for NWS Issued Prior to Fly Being Detected in the U.S.; Action Prepares Veterinarians and Pet Owners with Treatment Options First FDA ...
Herbal therapies are made from plants or botanicals and can be taken in a number of forms, including powders, tinctures, teas, capsules, and gels. Certain herbs are thought to help with various ...
With influenza already causing hospitalizations in Yankton, the message from health care providers is clear: October is a ...
This trial is the first and largest study specifically designed to evaluate children and adolescents with severe alopecia areata, a population often ...